• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problems Obstruction of Flow (2423); Activation Failure (3270)
Patient Problems Chest Pain (1776); Thrombosis/Thrombus (4440)
Event Date 05/23/2023
Event Type  Injury  
Event Description
It was reported that chest pain, stent thrombosis, insufficient apposition occurred requiring additional intervention.The patient came in for heart catheterization.A 2.75x24 synergy xd stent was implanted in the artery.Later that day, the patient presented with chest pain and acute stent thrombosis was noted.Intravenous ultrasound revealed that the stent was not properly apposed to the vessel wall and under expanded.A subsequent catheterization was performed by another physician to further expanded the stent against the vessel wall and the procedure was completed.No further complications were reported, and the patient has fully recovered.
 
Event Description
It was reported that chest pain, stent thrombosis, insufficient apposition occurred requiring additional intervention.The patient came in for heart catheterization.A 2.75x24 synergy xd stent was implanted in the artery.Later that day, the patient presented with chest pain and acute stent thrombosis was noted.Intravenous ultrasound revealed that the stent was not properly apposed to the vessel wall and under expanded.A subsequent catheterization was performed by another physician to further expanded the stent against the vessel wall and the procedure was completed.No further complications were reported and the patient has fully recovered.
 
Manufacturer Narrative
Corrected: h6: patient codes, h6: impact codes, h6: device codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17181185
MDR Text Key317641222
Report Number2124215-2023-32351
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-